000 | 01873cam a2200349 a 4500 | ||
---|---|---|---|
003 | EG-GiCUC | ||
005 | 20250223030801.0 | ||
008 | 130305s2012 ua dh f m 000 0 eng d | ||
040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
041 | 0 | _aeng | |
049 | _aDeposite | ||
097 | _aM.Sc | ||
099 | _aCai01.11.07.M.Sc.2012.Em.M | ||
100 | 0 | _aEman Fathy Ahmed Behary | |
245 | 1 | 0 |
_aMonocytes expression of soluble VEGF receptor-1 (sFLT-1) in patients with sickle cell nephropathy / _cEman Fathy Ahmed Behary ; Supervised Manal Michel Wilson , Rania Fawzy Hammoud . Ilham Youssry Ibrahim |
246 | 1 | 5 | _aتعبير الخلايا وحيدة النواة عن عامل نمو بطانة الأوعية الدموية الذائب في مرضى اعتلال الكلية المنجلي |
260 |
_aCairo : _bEman Fathy Ahmed Behary , _c2012 |
||
300 |
_a123 P. : _bcharts , facsimiles ; _c25cm |
||
502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology | ||
520 | _aThe anti-angiogenic factor soluble fms-like tyrosine kinase-1 (sFLT-1) is a member of the vascular endothelial growth factor receptor (VEGFR) family. sFLT-1 is produced due to misregulation of fms-like tyrosine kinase in the endothelial cells and the peripheral blood mononuclear cells resulting in over expression of the soluble splice variant of FLT-1 in the plasma and mononuclear cells | ||
530 | _aIssued also as CD | ||
653 | 4 | _aSickle nephropathy | |
653 | 4 | _aSoluble fms-like tyrosine kinase-1 | |
653 | 4 | _aVascular endothelial growth factor receptor | |
700 | 0 |
_aIlham Youssry Ibrahim , _eSupervisor |
|
700 | 0 |
_aManal Michel Wilson , _eSupervisor |
|
700 | 0 |
_aRania Fawzy Hammoud , _eSupervisor |
|
856 | _uhttp://172.23.153.220/th.pdf | ||
905 |
_aNazla _eRevisor |
||
905 |
_aSamia _eCataloger |
||
942 |
_2ddc _cTH |
||
999 |
_c41854 _d41854 |